Urszula Głowacka

490 total citations
20 papers, 399 citations indexed

About

Urszula Głowacka is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Urszula Głowacka has authored 20 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 9 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Urszula Głowacka's work include Neuroscience and Neuropharmacology Research (7 papers), Neurological disorders and treatments (6 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Urszula Głowacka is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Neurological disorders and treatments (6 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Urszula Głowacka collaborates with scholars based in Poland, United States and Canada. Urszula Głowacka's co-authors include Katarzyna Kuter, Krystyna Ossowska, Jadwiga Wardas, Marcin Magierowski, Tomasz Brzozowski, Katarzyna Magierowska, Michiru D. Sugawa, Norbert A. Dencher, Dagmara Wójcik and Marcin Surmiak and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Urszula Głowacka

20 papers receiving 395 citations

Peers

Countries citing papers authored by Urszula Głowacka

Since Specialization

Citations

This map shows the geographic impact of Urszula Głowacka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urszula Głowacka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urszula Głowacka more than expected).

Fields of papers citing papers by Urszula Głowacka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urszula Głowacka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urszula Głowacka. The network helps show where Urszula Głowacka may publish in the future.

Co-authorship network of co-authors of Urszula Głowacka

This figure shows the co-authorship network connecting the top 25 collaborators of Urszula Głowacka. A scholar is included among the top collaborators of Urszula Głowacka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urszula Głowacka. Urszula Głowacka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Physiological healing of chronic gastric ulcer is not impaired by the hydrogen sulphide (H2S)-releasing derivative of acetylsalicylic acid (ATB-340): functional and proteomic approaches 2024 ·Inflammopharmacology ·(unknown), Maciej Suski, Zbigniew Śliwowski, (unknown), Urszula Głowacka, Dagmara Wójcik, (unknown), (unknown), Tomasz Brzozowski, Marcin Magierowski, John L. Wallace, Katarzyna Magierowska	3
2	Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries 2023 ·Antioxidants ·Urszula Głowacka, Marcin Magierowski, Zbigniew Śliwowski, Jakub Cieszkowski, (unknown), Dagmara Wójcik, Anna Chmura, Tomasz Brzozowski, John L. Wallace, Katarzyna Magierowska	6
3	Chronic Lorcaserin Treatment Reverses the Nicotine Withdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats 2021 ·International Journal of Molecular Sciences ·Magdalena Zaniewska, Agnieszka Nikiforuk, Urszula Głowacka, (unknown), (unknown), Ewa Litwa, Marzena Maćkowiak	3
4	Microbiome Profile and Molecular Pathways Alterations in Gastrointestinal Tract by Hydrogen Sulfide-Releasing Nonsteroidal Anti-Inflammatory Drug (ATB-352): Insight into Possible Safer Polypharmacy 2021 ·Antioxidants and Redox Signaling ·Urszula Głowacka, Katarzyna Magierowska, Dagmara Wójcik, (unknown), (unknown), Jakub Cieszkowski, (unknown), Aleksandra Danielak, Marcin Surmiak, Anna Chmura, John L. Wallace, Marcin Magierowski	15
5	Increased Beta-Hydroxybutyrate Level Is Not Sufficient for the Neuroprotective Effect of Long-Term Ketogenic Diet in an Animal Model of Early Parkinson’s Disease. Exploration of Brain and Liver Energy Metabolism Markers 2021 ·International Journal of Molecular Sciences ·Katarzyna Kuter, (unknown), Urszula Głowacka, (unknown)	24
6	Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage 2020 ·Acta Pharmaceutica Sinica B ·(unknown), Marcin Surmiak, Xiaoxiao Yang, Dagmara Wójcik, (unknown), Zbigniew Śliwowski, (unknown), Grzegorz Buszewicz, Tomasz Brzozowski, Jakub Cieszkowski, Urszula Głowacka, Katarzyna Magierowska, Zhixiang Pan, Binghe Wang, Marcin Magierowski	39
7	Evidence for Cytoprotective Effect of Carbon Monoxide Donor in the Development of Acute Esophagitis Leading to Acute Esophageal Epithelium Lesions 2020 ·Cells ·Katarzyna Magierowska, (unknown), Dagmara Wójcik, (unknown), Aleksandra Danielak, Urszula Głowacka, Robert Pajdo, Grzegorz Buszewicz, (unknown), Marcin Surmiak, Sławomir Kwiecień, Anna Chmura, Marcin Magierowski, Tomasz Brzozowski	18
8	Synergisms, Discrepancies and Interactions between Hydrogen Sulfide and Carbon Monoxide in the Gastrointestinal and Digestive System Physiology, Pathophysiology and Pharmacology 2020 ·Biomolecules ·Urszula Głowacka, Tomasz Brzozowski, Marcin Magierowski	23
9	Adolescent social isolation affects parvalbumin expression in the medial prefrontal cortex in the MAM-E17 model of schizophrenia 2018 ·Metabolic Brain Disease ·Marzena Maćkowiak, (unknown), Urszula Głowacka, (unknown), Wiktor Bilecki	14
10	Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia 2018 ·Neurotoxicity Research ·(unknown), (unknown), Urszula Głowacka, (unknown), (unknown), (unknown)	15
11	Astrocyte support is important for the compensatory potential of the nigrostriatal system neurons during early neurodegeneration 2018 ·Journal of Neurochemistry ·Katarzyna Kuter, (unknown), Urszula Głowacka, (unknown)	24
12	Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA 2017 ·Molecular Neurobiology ·Katarzyna Kuter, (unknown), Urszula Głowacka	52
13	Tremorolytic effect of 5′‐chloro‐5′‐deoxy‐(±)‐ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline‐induced model in rats 2017 ·CNS Neuroscience & Therapeutics ·(unknown), Krystyna Ossowska, Urszula Głowacka, Jadwiga Wardas	12
14	Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease 2016 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Katarzyna Kuter, (unknown), (unknown), Urszula Głowacka, Michiru D. Sugawa, Krystyna Ossowska, Norbert A. Dencher	41
15	Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats 2015 ·PLoS ONE ·(unknown), Jadwiga Wardas, (unknown), Urszula Głowacka, Katarzyna Kuter, Krystyna Ossowska	32
16	Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson’s disease and after chronic pramipexole treatment 2015 ·Neuroscience ·(unknown), Jadwiga Wardas, (unknown), Helena Domin, Maria Śmiałowska, Urszula Głowacka, Krystyna Ossowska	5
17	Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline‐induced Model of Essential Tremor in Rats 2015 ·CNS Neuroscience & Therapeutics ·(unknown), Jadwiga Wardas, Urszula Głowacka, Subramaniam Ananthan, Krystyna Ossowska	18
18	Apomorphine enhances harmaline-induced tremor in rats 2014 ·Pharmacological Reports ·Krystyna Ossowska, Urszula Głowacka, (unknown), Jadwiga Wardas	14
19	Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats 2014 ·Neuropharmacology ·Krystyna Ossowska, Jadwiga Wardas, (unknown), Urszula Głowacka, Katarzyna Kuter, Andrzej Pilc, Stevin H. Zorn, Darı́o Doller	14
20	Pramipexole but not imipramine or fluoxetine reverses the “depressive-like” behaviour in a rat model of preclinical stages of Parkinson's disease 2014 ·Behavioural Brain Research ·(unknown), Katarzyna Kuter, Wacław Kolasiewicz, Urszula Głowacka, Anna Dziubina, Krystyna Ossowska, Jadwiga Wardas	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact